Abstract
SF3B1 as a novel therapeutic target in pancreatic ductal adenocarcinoma: antitumoral effects of the splicing inhibitor Pladienolide B
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.pan.2019.05.205
Journal: Pancreatology | Publication Date: Jun 1, 2019 |
SF3B1 as a novel therapeutic target in pancreatic ductal adenocarcinoma: antitumoral effects of the splicing inhibitor Pladienolide B
Join us for a 30 min session where you can share your feedback and ask us any queries you have